Zhong‐Ru Xie

Biochemistry, Genetics and Molecular BiologyComputer ScienceMedicineMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Engineering a PAM-flexible SpdCas9 variant as a universal gene repressor”.

Engineering a PAM-flexible SpdCas9 variant as a universal gene repressor

Nature Communications(2021)10.1038/s41467-021-27290-9

N/A

0DataRank · unranked

35 citations

Yuxi Teng, Ruihua Zhang, Yifei Wu, Lei Lou, Yusong Zou +4 more

Exploring and engineering PAM-diverse Streptococci Cas9 for PAM-directed bifunctional and titratable gene control in bacteria

Metabolic Engineering(2022)10.1016/j.ymben.2022.10.005

N/A

0DataRank · unranked

16 citations

Yuxi Teng, Xinyu Gong, Jianli Zhang, Yifei Wu, Lei Lou +4 more

Structural and spectroscopic characterization of RufO indicates a new biological role in rufomycin biosynthesis

Journal of Biological Chemistry(2023)10.1016/j.jbc.2023.105049

N/A

0DataRank · unranked

16 citations

Bingnan Li, Ephrahime S. Traore, Yifei Wu, Remigio Usai, Aimin Liu +3 more

Inhibition of N‐myristoyltransferase activity promotes androgen receptor degradation in prostate cancer

The Prostate(2023)10.1002/pros.24645

N/A

0DataRank · unranked

4 citations

Emmanuel Onobun, Chenming Ye, Lei Lou, Zanna Beharry, Zhong‐Ru Xie +4 more

Assay development and screening of inhibitors targeting the SARS-CoV-2 2′-O-methyltransferase NSP16

Pharmaceutical Science Advances(2025)10.1016/j.pscia.2025.100076

N/A

0DataRank · unranked

4 citations

Carl William Trieshmann, Subodh Kumar Samrat, Hongmin Li, Yifei Wu, Steven P. Maher +5 more